Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study to Evaluate Imetelstat (GRN163L) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Hematologic

The purpose of this study is to evaluate the efficacy and safety of imetelstat in transfusion dependent participants with low or intermediate-1 risk myelodysplastic syndrome (MDS) that is relapsed / refractory to erythropoiesis-stimulating agent (ESA) treatment.
Hematologic
II/III
Mohan, Sanjay
NCT02598661
VICCHEM2081

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: